Holen Sie sich die Stockscreener-App
77.68
0.97%
0.75
Handel nachbörslich:
77.98
0.30
+0.39%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt EW?
Forum
Prognose
Aktiensplit
Edwards Lifesciences Corp Aktie (EW) Neueste Nachrichten
Edwards Lifesciences Stock: Analyst Estimates & Ratings - Barchart.com
Structural Heart Devices Market Set to Expand and Reach ~USD 25 Billion by 2032 Amid Rising Demand for Minimally Invasive Solutions | DelveInsight - GlobeNewswire Inc.
FTC Moves to Block Edwards Lifesciences’ $945 Million Acquisition of JenaValve Over Competition Concerns - MSN
Edwards Lifesciences Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
FTC Sues to Block Edwards LifeSciences Medical Device Deal - MSN
FTC Sounds Alarm On Edwards’ Heart Device, M&A AttemptEdwards Lifesciences (NYSE:EW) - Benzinga
Edwards Lifesciences Leads Heart Device Market With Value Upside - Finimize
FTC seeks to block Edwards Lifesciences' acquisition of JenaValve - MSN
Edwards Lifesciences’ ALT-FLOW II Trial: A Key Update for Heart Failure Treatment - TipRanks
Baird Adjusts Price Target on Edwards Lifesciences to $81 From $79, Maintains Neutral Rating - MarketScreener
FTC moves to block Edwards’ acquisition of JenaValve Technology - Medical Buyer
FTC seeks to block Edwards Lifesciences’ acquisition of JenaValve - WKZO
FTC sues to block Edwards Lifesciences' $945M JenaValve deal - Daily Journal
Decoding Edwards Lifesciences Corp (EW): A Strategic SWOT Insigh - GuruFocus
FTC sues to block Edwards Lifesciences purchase of JenaValve - MSN
FTC seeks to block Edwards Lifesciences' acquisition of JenaValve | Business Information & News | FE - Westlaw Today
South Africa Advocacy Groups Push to Reopen Vertex Antitrust Probe - PYMNTS.com
FTC Files Lawsuit to Block Edwards Lifesciences’ Purchase of JenaValve Technology - The Wall Street Journal
Edwards Lifesciences' deal with JenaValve would limit device access, US FTC says - MLex
FTC moves to block Edwards Lifesciences’ JenaValve acquisition - MassDevice
JenaValve Responds to FTC’s Action Against Proposed Edwards Lifesciences Acquisition - The Manila Times
Jenavalve disagrees with FTC's decision against proposed Edwards Lifesciences deal - MarketScreener
FTC seeks to block Edwards Lifesciences’ acquisition of JenaValve By Reuters - Investing.com
Edwards Lifesciences Comments on FTC’s Action to Block Proposed Acquisition of JenaValve - Yahoo Finance
Edwards Lifesciences Stock: Likely To See Sluggish Price Action Through 2027 - Benzinga
Edwards Lifesciences Corporation's (NYSE:EW) Stock Been Rising: Are Strong Financials Guiding The Market? - Yahoo Finance
How volatile is Edwards Lifesciences Corporation stock compared to the marketFree Stock Selection - Jammu Links News
Is Edwards Lifesciences Corporation a growth stock or a value stockHigh-octane investment gains - Jammu Links News
What catalysts could drive Edwards Lifesciences Corporation stock higher in 2025Build wealth with professional market analysis - Jammu Links News
Is it the right time to buy Edwards Lifesciences Corporation stockSuperior portfolio returns - Jammu Links News
How many analysts rate Edwards Lifesciences Corporation as a “Buy”Strongest growth potential - Jammu Links News
What are the technical indicators suggesting about Edwards Lifesciences CorporationMarket-crushing stock picks - Jammu Links News
Should I hold or sell Edwards Lifesciences Corporation stock in 2025Real Time Alerts For Fast Growth - Jammu Links News
Edwards Lifesciences’ SAPIEN 3 Valve Study: A Real-World Evaluation - TipRanks
Edwards Lifesciences’ PASCAL System: A Promising Update in Tricuspid Valve Repair - TipRanks
Agree To Purchase Edwards Lifesciences At $65, Earn 5.2% Using Options - Nasdaq
How Edwards Lifesciences Corporation stock reacts to Fed policy changesAI Powered High Return Stock Calls Dominate Watchlists - beatles.ru
Baron Health Care Fund Reacquired Edwards Lifesciences Corporation (EW) in Q2. Here’s Why - Yahoo Finance
Edwards Lifesciences’ SAPIEN 3 Study: A Market Game-Changer? - TipRanks
A Quick Look at Today's Ratings for Edwards Lifesciences(EW.US), With a Forecast Between $84 to $100 - 富途牛牛
Edwards Lifesciences Stock (EW) Opinions on Q2 Earnings Beat - Quiver Quantitative
Edwards Lifesciences’ Pivotal Trial: A Game-Changer for Tricuspid Valve Repair? - TipRanks
Edwards Lifesciences Corporation (NYSE:EW) Q2 2025 Earnings Call Transcript - Insider Monkey
Analysts upgrade Edwards as TAVR segment improves - MassDevice
BTIG upgrades Edwards Lifesciences stock to Buy on TAVR segment stability - Investing.com
Edwards Lifesciences prevails in heart valve dispute at the UPC - JUVE Patent
1.24%
0.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):